Kimihiko Ito

C4gr Green
Tsukuba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

An air-electrode with hierarchically continuous pore architecture: a step toward "true" lithium-air batteries working with atmospheric oxygen.

An air-electrode with hierarchically continuous pore architecture: a step toward "true" lithium-air batteries working with atmospheric oxygen.

Journal: Science and technology of advanced materials

Published: May 14, 2026

Clinicopathologic features and outcomes of patients with microsatellite instability-high endometrial cancer treated with pembrolizumab in Japan: the KCOG-G1902S/1903S study.

Clinicopathologic features and outcomes of patients with microsatellite instability-high endometrial cancer treated with pembrolizumab in Japan: the KCOG-G1902S/1903S study.

Journal: Journal of gynecologic oncology

Published: March 09, 2026

Primary Peritoneal Pregnancy Requiring Conversion From Laparoscopic to Open Surgery Due to Massive Hemorrhage: A Case Report.

Primary Peritoneal Pregnancy Requiring Conversion From Laparoscopic to Open Surgery Due to Massive Hemorrhage: A Case Report.

Journal: Cureus

Published: February 11, 2026

Long-term progression-free survivors ("super responders") to olaparib maintenance in recurrent ovarian cancer: a multicenter real-world study (KCOG-G2101s).

Long-term progression-free survivors ("super responders") to olaparib maintenance in recurrent ovarian cancer: a multicenter real-world study (KCOG-G2101s).

Journal: International journal of clinical oncology

Published: October 30, 2025

cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancer.

cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancer.

Journal: Journal of gynecologic oncology

Published: October 10, 2025

Prognostic factors for malignant tumors arising from mature cystic teratomas: a study involving the Kansai Clinical Oncology Group (KCOG-G1305s study).

Prognostic factors for malignant tumors arising from mature cystic teratomas: a study involving the Kansai Clinical Oncology Group (KCOG-G1305s study).

Journal: Archives of gynecology and obstetrics

Published: May 29, 2025

Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study.

Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study.

Journal: Gynecologic oncology reports

Published: February 14, 2025

The association between additional radiotherapy after systemic chemotherapy and the prognosis of stage FIGO 2018 IVB cervical cancer.

The association between additional radiotherapy after systemic chemotherapy and the prognosis of stage FIGO 2018 IVB cervical cancer.

Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Published: November 06, 2024

Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer.

Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer.

Journal: Journal of gynecologic oncology

Published: June 14, 2024

Combination therapy of oral cyclophosphamide and bevacizumab for patients with recurrent ovarian and peritoneal cancer.

Combination therapy of oral cyclophosphamide and bevacizumab for patients with recurrent ovarian and peritoneal cancer.

Journal: Medicine

Published: February 24, 2023

Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601.

Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601.

Journal: Anti-cancer drugs

Published: February 02, 2023

Metastatic Tumor of the Uterine Cervical Cancer Occurred in the Infratemporal Fossa

Metastatic Tumor of the Uterine Cervical Cancer Occurred in the Infratemporal Fossa

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: December 20, 2022

Showing 1-12 of 64

Last Updated: 09/26/2026